CME Group Now Rated a “Buy” at UBS (CME)

By
A A A
Share |

Futures exchange operator CME Group Inc. ( CME ) on Friday saw its rating and price target boosted by analysts at UBS.

The firm said it upgraded CME from "Neutral" to "Buy" with a $318 price target. That target suggests a 20% upside to the stock's Thursday closing price of $266.25.

Analysts at UBS noted the company has both cyclical and secular growth potential.

CME shares rose $3.75, or +1.4%, in premarket trading Friday.

The Bottom Line
Shares of CME Group ( CME ) have a 2.10% dividend yield, based on last night's closing stock price of $266.25. The stock has technical support in the $250-$260 price area. If the shares can firm up, we see overhead resistance around the $280 price level.

CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: CME

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stuck
Stuck                               
Yoga Surfer
Yoga Surfer                         

Stocks

Referenced

67%

Most Active by Volume

89,851,277
  • $17.05 ▲ 0.12%
61,694,953
  • $39.05 ▲ 1.03%
61,622,467
  • $102.64 ▲ 1.56%
56,476,509
  • $3.48 ▼ 1.14%
49,282,352
  • $5.31 ▲ 3.91%
37,301,083
  • $87.17 ▼ 3.03%
36,192,897
  • $78.29 ▲ 1.94%
33,401,171
  • $38.83 ▼ 1.89%
As of 9/23/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com